Bai Xihe: professor title, professor of treatment.　An expert enjoying a special subsidy granted by State Council, known for his TCM-Western medicine combination therapy for tumor treatment, listed as the chief expert on Oncology in the Chinese TCM Research Institute.For over 40 years, Professor Bai Xihe has committed to the

clinical trial,education and scientific research work relating to tumor treatment, and has published more than 30 medical papers, 5 self-composed works and translated books, and has been awarded with a second-prize for scientific and technical fruits by the Ministry of Health. 　Professor Bai excels at the treatment of medium- and terminal-stage liver cancer, lung cancer, gastric cancer, esophagus cancer, rectum cancer, lymph node cancer, breast carcinoma, uterus carcinoma, adenocarcinoma of pancreas, carcinoma of gallbladder, carcinoma of bladder, encephaloma and bone tumor by integrating TCM theory with modern medicine in an appropriate way.　Even for those who are unable to receive surgery, radiotherapy or chemotherapy, both the quality and the span of life can be improved and prolonged.　
－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－

Wang Pei: professor title, professor of treatment. 　An expert enjoying a special subsidy granted by State Council, known for the TCM approach for tumor treatment, working as a professor and Ph.D tutor in Beijing University of Chinese Medicine.

After graduation, Professor Wang Pei has dedicated to the clinical treatment, medical education and scientific research relating to tumor treatment, and has published more than 10 self-composed works and accumulated abundant clinical experience.　 Wang is adept in the treatment of solid tumors, such as liver cancer, gastric carcinoma, lung cancer, esophagus cancer, adenocarcinoma of pancreas and carcinoma of colon; in particular, Wang’s contributions to the prevention and alleviation of post-surgery recurrence, metastasis, .cancer-induced pains and toxicity resulting from radiotherapy and chemotherapy are remarkable.　 For over 40 years, Professor Wang Pei has successfully mitigated the pain and prolong the life of tens of thousands of patients at the medium- and terminal-stage.
－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－

Li Peiwen: professor title, professor of treatment. An expert enjoying a special subsidy granted by State Council, working as a director of TCM Tumor Sector in China-Japan Friendship Hospital affiliated to the Ministry of Health of the PRC, and a professor & Ph.D tutor in Beijing University of Chinese Medicine, also known as a member of CPPCC.

After graduation, Professor Li Peiwen has devoted himself to the undertaking of clinical treatment of tumor by TCM & TCM-Western Medicine combination therapies. For over 30 years, he has chaired and participated in the tackling of key problems that are listed in the national “Eighth ‘Five-Year Plan’ ”, “Ninth ‘Five-Year Plan’ ”, “Tenth ‘Five-Year Plan’ ” and those proposed by State Administration of Traditional Chinese Medicine of the PRC.　 Besides, he has been awarded for several times and has published more than 60 papers. Professor Li Peiwen is specialized in the treatment of all kinds of cancers; in particular, for those at the medium and terminal stage, Li has made outstanding achievement in alleviating symptoms, maintaining & improving living quality and extending life-span.
－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－

Cui Yongwang: professor title, professor of treatment. 　An expert working as the director of Cancer Foundation of China, the former chief of Cancer Centre of the Beijing Railway General Hospital affiliated to the Ministry of Railway, the chief specialist of Tumor Sector in Andingmen Chinese Medicine Hospital of Beijing.

After his graduation from Southeast University (former Nanjing Railway Medical College affiliated to the Ministry of Railway) in 1967, Professor Cui Yongwang has been engaged in the undertaking of surgical treatment, medical chemotherapy, biological immuno-therapy as well as the integrated therapy of TCM, developing a cutting edge in the treatment of medium- and terminal-stage tumor of alimentary tract in a TCM-Western Medicine combination approach.　 He argues that the TCM should be applied to the whole process of tumor treatment, and the recuperation and terminal-stage treatment of tumor should be carried out with TCM therapy as its core.
－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－

Zhou Lixiao: professor title, professor of treatment. 　An expert known as the former standing associate director of Chinese National TCM Examination Centre and the chief specialist of TCM Gynaecology Sector in Andingmen Chinese Medicine Hospital of Beijing.

With a persistent faith in integration of clinical experience, education and research, Professor Zhou Lixiao has laid a solid foundation of medical theory while accumulating rich clinical experiences.　 He excels in the treatment of various gynecological tumors and sterility in a TCM approach; in particular, he has made unique achievement in the treatment of oophoritic cyst　 by applying the novel and miracle therapy of internal TCM administering plus external TCM pediluvium 。　 In real practice, patients will recover after 1-2 periods of treatment, and this therapy has been warmly welcomed and received broad appraise from the beneficiaries.
－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－

Geng Wanyuan：associate professor of treatment. 　An expert working as the director of Chinese TCM Anti-Cancer Academy, the director of Tumor Commission of China TCM-Western Medicine Clinical Medical Association, and the director of TCM Tumor Sector of Andingmen Chinese Medicine Hospital of Beijing.

irector Geng Wanyuan is specialized the TCM treatment of tumors, with an extraordinarily abundant experience in breast tumor treatment. He upholds that those who receive surgery, radiotherapy or chemotherapy should administer TCM to reinforce the curative effect. 　For many years, Mr. Geng has summed up a series of TCM atoxic anti-cancer recipes which possess a unique effect for the recuperation treatment of post-operation, radiotherapy or chemotherapy patients.